Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

6 May 2010 07:00

Thursday 6 May 2010 SOPHEON PLC ("Sopheon" or the "Company") INTERIM MANAGEMENT STATEMENT Sopheon plc, the international provider of software and services that improvethe financial return from innovation and product development investments,announces its first interim management statement for the period since 1 January2010 to the date of this announcement, in line with the requirements of the EUTransparency Directive.Sopheon has continued to add business since the end of last year, building onthe improved performance of the fourth quarter. Since the start of 2010, wehave closed 12 new and extension license orders. Business from existingcustomers continues to hold up well. Revenue visibility for the full year fromcontracted business and recurring revenue streams now stands at £5.6 million,compared to £4.8 million on 24 March, the time of our last update. Totalreported revenue for 2009 was £8.3 million. Operating costs before R&Dcapitalization were approximately £0.5 million lower in the first quarter of2010 compared to the first quarter of 2009, reflecting the fact that costadjustments taken last year took effect in the second quarter. Gross cashresources at the end of the first quarter of 2010 stood at £1.7 million.The market is responding favourably to the new product enhancements that weintroduced in 2009. Since the start of the year we have continued to innovateand deliver new solutions. Most recently, we announced the launch of www.isustain.com in partnership with Cytec Industries and the Beyond BenignFoundation. The site enables users to assess the sustainability of productformulations through an iSUSTAIN Green Chemistry Index rating, which can beindependently certified if required. Users that wish to migrate beyond a basiclevel of interaction with the site will be required to enter into paid-forsubscriptions.Our sales pipeline continues to show encouraging activity, and suggests aresurgent appetite amongst large corporations to make positive purchasedecisions where they perceive real business benefits. Predicting the timing andvalue of individual sales remains challenging, which can inevitably impact onthe business performance. However, major analyst organisations like Forrester,Gartner and IDC continue to see growing traction and opportunity in our chosenmarket. In December 2009, Forrester noted increasing interest and investment inproject and portfolio management tools for product development (PPM) and in thesame month Gartner noted that software that supports product strategy andplanning is gaining attention as a segment of the product lifecycle management(PLM) software market. Forrester also identified Sopheon as one of the clearmarket share leaders in the PPM space.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Justine James / Hansard Communications Tel : + 44 (0) 20 7245 1100 Kirsty Corcoran Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 Catherine Leftley / Seymour Pierce Corporate Tel: +44 (0) 20 7107 8000 Jonathan Wright Finance About SopheonSopheon is an international provider of software and services thathelp organisations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon's solutions are used byindustry leaders throughout the world, including BASF, Cadbury, Corning,Electrolux, Honeywell, Motorola and SABMiller. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.

vendor
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.